Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation
- PMID: 11709720
- DOI: 10.1038/sj.onc.1204950
Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation
Abstract
Ras genes, frequently mutated in human tumors, promote malignant transformation. Ras transformation requires membrane anchorage, which is promoted by Ras farnesylcysteine carboxymethylester and by a second signal. Previously we showed that the farnesylcysteine mimetic, farnesylthiosalicylic acid (FTS) disrupts Ras membrane anchorage. To understand how this disruption contributes to inhibition of cell transformation we searched for new Ras-interacting proteins and identified galectin-1, a lectin implicated in human tumors, as a selective binding partner of oncogenic H-Ras(12V). The observed size of H-Ras(12V)-galectin-1 complex, which is equal to the sum of the molecular weights of Ras and galectin-1 indicates a direct binding interaction between the two proteins. FTS disrupted H-Ras(12V)-galectin-1 interactions. Overexpression of galectin-1 increased membrane-associated Ras, Ras-GTP, and active ERK resulting in cell transformation, which was blocked by dominant negative Ras. Galectin-1 antisense RNA inhibited transformation by H-Ras(12V) and abolished membrane anchorage of green fluorescent protein (GFP)-H-Ras(12V) but not of GFP-H-Ras wild-type (wt), GFP-K-Ras(12V), or GFP-N-Ras(13V). H-Ras(12V)-galectin-1 interactions establish an essential link between two proteins associated with cell transformation and human malignancies that can be exploited to selectively target oncogenic Ras proteins.
Similar articles
-
Galectin-3 augments K-Ras activation and triggers a Ras signal that attenuates ERK but not phosphoinositide 3-kinase activity.J Biol Chem. 2004 Aug 13;279(33):34922-30. doi: 10.1074/jbc.M312697200. Epub 2004 Jun 17. J Biol Chem. 2004. PMID: 15205467
-
Essential role of Raf in Ras transformation and deregulation of matrix metalloproteinase expression in ovarian epithelial cells.Mol Cancer Res. 2003 Dec;1(14):1077-88. Mol Cancer Res. 2003. PMID: 14707291
-
Galectin-3 regulates a molecular switch from N-Ras to K-Ras usage in human breast carcinoma cells.Cancer Res. 2005 Aug 15;65(16):7292-300. doi: 10.1158/0008-5472.CAN-05-0775. Cancer Res. 2005. PMID: 16103080
-
The ras/cholesterol connection: implications for ras oncogenicity.Crit Rev Oncog. 1992;3(4):365-400. Crit Rev Oncog. 1992. PMID: 1420445 Review.
-
The Ras-Membrane Interface: Isoform-specific Differences in The Catalytic Domain.Mol Cancer Res. 2015 Apr;13(4):595-603. doi: 10.1158/1541-7786.MCR-14-0535. Epub 2015 Jan 7. Mol Cancer Res. 2015. PMID: 25566993 Review.
Cited by
-
Cellular FRET-Biosensors to Detect Membrane Targeting Inhibitors of N-Myristoylated Proteins.PLoS One. 2013 Jun 18;8(6):e66425. doi: 10.1371/journal.pone.0066425. Print 2013. PLoS One. 2013. PMID: 23824448 Free PMC article.
-
ASPP2 Is a Novel Pan-Ras Nanocluster Scaffold.PLoS One. 2016 Jul 20;11(7):e0159677. doi: 10.1371/journal.pone.0159677. eCollection 2016. PLoS One. 2016. PMID: 27437940 Free PMC article.
-
Structural basis for galectin-1-dependent pre-B cell receptor (pre-BCR) activation.J Biol Chem. 2012 Dec 28;287(53):44703-13. doi: 10.1074/jbc.M112.395152. Epub 2012 Nov 2. J Biol Chem. 2012. PMID: 23124203 Free PMC article.
-
Pathway- and expression level-dependent effects of oncogenic N-Ras: p27(Kip1) mislocalization by the Ral-GEF pathway and Erk-mediated interference with Smad signaling.Mol Cell Biol. 2005 Sep;25(18):8239-50. doi: 10.1128/MCB.25.18.8239-8250.2005. Mol Cell Biol. 2005. PMID: 16135812 Free PMC article.
-
Galectin-1 as a potential cancer target.Br J Cancer. 2005 Apr 11;92(7):1188-92. doi: 10.1038/sj.bjc.6602493. Br J Cancer. 2005. PMID: 15785741 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
